Global Next-Generation Antibody Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Next-Generation Antibody Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next-Generation Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Antibody Drug that contribute to its increasing demand across many markets.
The global Next-Generation Antibody Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Next-Generation Antibody Drug total production and demand, 2017-2028, (K Units)
Global Next-Generation Antibody Drug total production value, 2017-2028, (USD Million)
Global Next-Generation Antibody Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Next-Generation Antibody Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Next-Generation Antibody Drug domestic production, consumption, key domestic manufacturers and share
Global Next-Generation Antibody Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Next-Generation Antibody Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Next-Generation Antibody Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Next-Generation Antibody Drug market based on the following parameters – headquarters, production locations, products portfolio, Next-Generation Antibody Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Antibody Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Next-Generation Antibody Drug Market, By Region:
1. How big is the global Next-Generation Antibody Drug market?
2. What is the demand of the global Next-Generation Antibody Drug market?
3. What is the year over year growth of the global Next-Generation Antibody Drug market?
4. What is the production and production value of the global Next-Generation Antibody Drug market?
5. Who are the key producers in the global Next-Generation Antibody Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Next-Generation Antibody Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Antibody Drug that contribute to its increasing demand across many markets.
The global Next-Generation Antibody Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Next-Generation Antibody Drug total production and demand, 2017-2028, (K Units)
Global Next-Generation Antibody Drug total production value, 2017-2028, (USD Million)
Global Next-Generation Antibody Drug production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Next-Generation Antibody Drug consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Next-Generation Antibody Drug domestic production, consumption, key domestic manufacturers and share
Global Next-Generation Antibody Drug production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Next-Generation Antibody Drug production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Next-Generation Antibody Drug production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Next-Generation Antibody Drug market based on the following parameters – headquarters, production locations, products portfolio, Next-Generation Antibody Drug revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Antibody Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Next-Generation Antibody Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Fragment-Based
- IgG-Based
- Cancer
- Hemophilia
- Other Diseases
- Roche
- Amgen
- Janssen
- Sanofi
- Pfizer
- Johnson & Johnson
- AstraZeneca
- AbbVie
- Lindis Biotech
- MacroGenics, Inc
- Genmab
- Alphamab Oncology
- Akeso
- Innovent Biologics
- Yzy Medical Science & Technology
1. How big is the global Next-Generation Antibody Drug market?
2. What is the demand of the global Next-Generation Antibody Drug market?
3. What is the year over year growth of the global Next-Generation Antibody Drug market?
4. What is the production and production value of the global Next-Generation Antibody Drug market?
5. Who are the key producers in the global Next-Generation Antibody Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Next-Generation Antibody Drug Introduction
1.2 World Next-Generation Antibody Drug Supply & Forecast
1.2.1 World Next-Generation Antibody Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Next-Generation Antibody Drug Production (2017-2028)
1.2.3 World Next-Generation Antibody Drug Pricing Trends (2017-2028)
1.3 World Next-Generation Antibody Drug Production by Region
1.3.1 World Next-Generation Antibody Drug Production Value by Region (2017-2028)
1.3.2 World Next-Generation Antibody Drug Production by Region (2017-2028)
1.3.3 World Next-Generation Antibody Drug Average Price by Region (2017-2028)
1.3.4 North America Next-Generation Antibody Drug Production (2017-2028)
1.3.5 Europe Next-Generation Antibody Drug Production (2017-2028)
1.3.6 China Next-Generation Antibody Drug Production (2017-2028)
1.3.7 Japan Next-Generation Antibody Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Antibody Drug Demand (2017-2028)
2.2 World Next-Generation Antibody Drug Consumption by Region
2.2.1 World Next-Generation Antibody Drug Consumption by Region (2017-2022)
2.2.2 World Next-Generation Antibody Drug Consumption Forecast by Region (2023-2028)
2.3 United States Next-Generation Antibody Drug Consumption (2017-2028)
2.4 China Next-Generation Antibody Drug Consumption (2017-2028)
2.5 Europe Next-Generation Antibody Drug Consumption (2017-2028)
2.6 Japan Next-Generation Antibody Drug Consumption (2017-2028)
2.7 South Korea Next-Generation Antibody Drug Consumption (2017-2028)
2.8 ASEAN Next-Generation Antibody Drug Consumption (2017-2028)
2.9 India Next-Generation Antibody Drug Consumption (2017-2028)
3 WORLD NEXT-GENERATION ANTIBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Next-Generation Antibody Drug Production Value by Manufacturer (2017-2022)
3.2 World Next-Generation Antibody Drug Production by Manufacturer (2017-2022)
3.3 World Next-Generation Antibody Drug Average Price by Manufacturer (2017-2022)
3.4 Next-Generation Antibody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Next-Generation Antibody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Next-Generation Antibody Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Next-Generation Antibody Drug in 2021
3.6 Next-Generation Antibody Drug Market: Overall Company Footprint Analysis
3.6.1 Next-Generation Antibody Drug Market: Region Footprint
3.6.2 Next-Generation Antibody Drug Market: Company Product Type Footprint
3.6.3 Next-Generation Antibody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Next-Generation Antibody Drug Production Value Comparison
4.1.1 United States VS China: Next-Generation Antibody Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Next-Generation Antibody Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Next-Generation Antibody Drug Production Comparison
4.2.1 United States VS China: Next-Generation Antibody Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Next-Generation Antibody Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Next-Generation Antibody Drug Consumption Comparison
4.3.1 United States VS China: Next-Generation Antibody Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Next-Generation Antibody Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Next-Generation Antibody Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Next-Generation Antibody Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Next-Generation Antibody Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Antibody Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Fragment-Based
5.2.2 IgG-Based
5.3 Market Segment by Type
5.3.1 World Next-Generation Antibody Drug Production by Type (2017-2028)
5.3.2 World Next-Generation Antibody Drug Production Value by Type (2017-2028)
5.3.3 World Next-Generation Antibody Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Antibody Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Hemophilia
6.2.3 Other Diseases
6.3 Market Segment by Application
6.3.1 World Next-Generation Antibody Drug Production by Application (2017-2028)
6.3.2 World Next-Generation Antibody Drug Production Value by Application (2017-2028)
6.3.3 World Next-Generation Antibody Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Next-Generation Antibody Drug Product and Services
7.1.4 Roche Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Next-Generation Antibody Drug Product and Services
7.2.4 Amgen Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Janssen
7.3.1 Janssen Details
7.3.2 Janssen Major Business
7.3.3 Janssen Next-Generation Antibody Drug Product and Services
7.3.4 Janssen Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Janssen Recent Developments/Updates
7.3.6 Janssen Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Next-Generation Antibody Drug Product and Services
7.4.4 Sanofi Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Next-Generation Antibody Drug Product and Services
7.5.4 Pfizer Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Next-Generation Antibody Drug Product and Services
7.6.4 Johnson & Johnson Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Next-Generation Antibody Drug Product and Services
7.7.4 AstraZeneca Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 AbbVie
7.8.1 AbbVie Details
7.8.2 AbbVie Major Business
7.8.3 AbbVie Next-Generation Antibody Drug Product and Services
7.8.4 AbbVie Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 AbbVie Recent Developments/Updates
7.8.6 AbbVie Competitive Strengths & Weaknesses
7.9 Lindis Biotech
7.9.1 Lindis Biotech Details
7.9.2 Lindis Biotech Major Business
7.9.3 Lindis Biotech Next-Generation Antibody Drug Product and Services
7.9.4 Lindis Biotech Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lindis Biotech Recent Developments/Updates
7.9.6 Lindis Biotech Competitive Strengths & Weaknesses
7.10 MacroGenics, Inc
7.10.1 MacroGenics, Inc Details
7.10.2 MacroGenics, Inc Major Business
7.10.3 MacroGenics, Inc Next-Generation Antibody Drug Product and Services
7.10.4 MacroGenics, Inc Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 MacroGenics, Inc Recent Developments/Updates
7.10.6 MacroGenics, Inc Competitive Strengths & Weaknesses
7.11 Genmab
7.11.1 Genmab Details
7.11.2 Genmab Major Business
7.11.3 Genmab Next-Generation Antibody Drug Product and Services
7.11.4 Genmab Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Genmab Recent Developments/Updates
7.11.6 Genmab Competitive Strengths & Weaknesses
7.12 Alphamab Oncology
7.12.1 Alphamab Oncology Details
7.12.2 Alphamab Oncology Major Business
7.12.3 Alphamab Oncology Next-Generation Antibody Drug Product and Services
7.12.4 Alphamab Oncology Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Alphamab Oncology Recent Developments/Updates
7.12.6 Alphamab Oncology Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso Next-Generation Antibody Drug Product and Services
7.13.4 Akeso Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Innovent Biologics
7.14.1 Innovent Biologics Details
7.14.2 Innovent Biologics Major Business
7.14.3 Innovent Biologics Next-Generation Antibody Drug Product and Services
7.14.4 Innovent Biologics Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Innovent Biologics Recent Developments/Updates
7.14.6 Innovent Biologics Competitive Strengths & Weaknesses
7.15 Yzy Medical Science & Technology
7.15.1 Yzy Medical Science & Technology Details
7.15.2 Yzy Medical Science & Technology Major Business
7.15.3 Yzy Medical Science & Technology Next-Generation Antibody Drug Product and Services
7.15.4 Yzy Medical Science & Technology Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Yzy Medical Science & Technology Recent Developments/Updates
7.15.6 Yzy Medical Science & Technology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Next-Generation Antibody Drug and Key Manufacturers
8.2 Next-Generation Antibody Drug Manufacturing Costs
8.3 Next-Generation Antibody Drug Production Process
8.4 Next-Generation Antibody Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Next-Generation Antibody Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Next-Generation Antibody Drug Typical Distributors
9.3 Next-Generation Antibody Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Next-Generation Antibody Drug Introduction
1.2 World Next-Generation Antibody Drug Supply & Forecast
1.2.1 World Next-Generation Antibody Drug Production Value (2017 & 2021 & 2028)
1.2.2 World Next-Generation Antibody Drug Production (2017-2028)
1.2.3 World Next-Generation Antibody Drug Pricing Trends (2017-2028)
1.3 World Next-Generation Antibody Drug Production by Region
1.3.1 World Next-Generation Antibody Drug Production Value by Region (2017-2028)
1.3.2 World Next-Generation Antibody Drug Production by Region (2017-2028)
1.3.3 World Next-Generation Antibody Drug Average Price by Region (2017-2028)
1.3.4 North America Next-Generation Antibody Drug Production (2017-2028)
1.3.5 Europe Next-Generation Antibody Drug Production (2017-2028)
1.3.6 China Next-Generation Antibody Drug Production (2017-2028)
1.3.7 Japan Next-Generation Antibody Drug Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next-Generation Antibody Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next-Generation Antibody Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next-Generation Antibody Drug Demand (2017-2028)
2.2 World Next-Generation Antibody Drug Consumption by Region
2.2.1 World Next-Generation Antibody Drug Consumption by Region (2017-2022)
2.2.2 World Next-Generation Antibody Drug Consumption Forecast by Region (2023-2028)
2.3 United States Next-Generation Antibody Drug Consumption (2017-2028)
2.4 China Next-Generation Antibody Drug Consumption (2017-2028)
2.5 Europe Next-Generation Antibody Drug Consumption (2017-2028)
2.6 Japan Next-Generation Antibody Drug Consumption (2017-2028)
2.7 South Korea Next-Generation Antibody Drug Consumption (2017-2028)
2.8 ASEAN Next-Generation Antibody Drug Consumption (2017-2028)
2.9 India Next-Generation Antibody Drug Consumption (2017-2028)
3 WORLD NEXT-GENERATION ANTIBODY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Next-Generation Antibody Drug Production Value by Manufacturer (2017-2022)
3.2 World Next-Generation Antibody Drug Production by Manufacturer (2017-2022)
3.3 World Next-Generation Antibody Drug Average Price by Manufacturer (2017-2022)
3.4 Next-Generation Antibody Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Next-Generation Antibody Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Next-Generation Antibody Drug in 2021
3.5.3 Global Concentration Ratios (CR8) for Next-Generation Antibody Drug in 2021
3.6 Next-Generation Antibody Drug Market: Overall Company Footprint Analysis
3.6.1 Next-Generation Antibody Drug Market: Region Footprint
3.6.2 Next-Generation Antibody Drug Market: Company Product Type Footprint
3.6.3 Next-Generation Antibody Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Next-Generation Antibody Drug Production Value Comparison
4.1.1 United States VS China: Next-Generation Antibody Drug Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Next-Generation Antibody Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Next-Generation Antibody Drug Production Comparison
4.2.1 United States VS China: Next-Generation Antibody Drug Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Next-Generation Antibody Drug Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Next-Generation Antibody Drug Consumption Comparison
4.3.1 United States VS China: Next-Generation Antibody Drug Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Next-Generation Antibody Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Next-Generation Antibody Drug in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
4.5 China Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Next-Generation Antibody Drug in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Next-Generation Antibody Drug Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Next-Generation Antibody Drug in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Next-Generation Antibody Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Fragment-Based
5.2.2 IgG-Based
5.3 Market Segment by Type
5.3.1 World Next-Generation Antibody Drug Production by Type (2017-2028)
5.3.2 World Next-Generation Antibody Drug Production Value by Type (2017-2028)
5.3.3 World Next-Generation Antibody Drug Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next-Generation Antibody Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Hemophilia
6.2.3 Other Diseases
6.3 Market Segment by Application
6.3.1 World Next-Generation Antibody Drug Production by Application (2017-2028)
6.3.2 World Next-Generation Antibody Drug Production Value by Application (2017-2028)
6.3.3 World Next-Generation Antibody Drug Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Next-Generation Antibody Drug Product and Services
7.1.4 Roche Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Next-Generation Antibody Drug Product and Services
7.2.4 Amgen Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Janssen
7.3.1 Janssen Details
7.3.2 Janssen Major Business
7.3.3 Janssen Next-Generation Antibody Drug Product and Services
7.3.4 Janssen Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Janssen Recent Developments/Updates
7.3.6 Janssen Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Next-Generation Antibody Drug Product and Services
7.4.4 Sanofi Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Next-Generation Antibody Drug Product and Services
7.5.4 Pfizer Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Next-Generation Antibody Drug Product and Services
7.6.4 Johnson & Johnson Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 AstraZeneca
7.7.1 AstraZeneca Details
7.7.2 AstraZeneca Major Business
7.7.3 AstraZeneca Next-Generation Antibody Drug Product and Services
7.7.4 AstraZeneca Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 AstraZeneca Recent Developments/Updates
7.7.6 AstraZeneca Competitive Strengths & Weaknesses
7.8 AbbVie
7.8.1 AbbVie Details
7.8.2 AbbVie Major Business
7.8.3 AbbVie Next-Generation Antibody Drug Product and Services
7.8.4 AbbVie Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 AbbVie Recent Developments/Updates
7.8.6 AbbVie Competitive Strengths & Weaknesses
7.9 Lindis Biotech
7.9.1 Lindis Biotech Details
7.9.2 Lindis Biotech Major Business
7.9.3 Lindis Biotech Next-Generation Antibody Drug Product and Services
7.9.4 Lindis Biotech Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lindis Biotech Recent Developments/Updates
7.9.6 Lindis Biotech Competitive Strengths & Weaknesses
7.10 MacroGenics, Inc
7.10.1 MacroGenics, Inc Details
7.10.2 MacroGenics, Inc Major Business
7.10.3 MacroGenics, Inc Next-Generation Antibody Drug Product and Services
7.10.4 MacroGenics, Inc Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 MacroGenics, Inc Recent Developments/Updates
7.10.6 MacroGenics, Inc Competitive Strengths & Weaknesses
7.11 Genmab
7.11.1 Genmab Details
7.11.2 Genmab Major Business
7.11.3 Genmab Next-Generation Antibody Drug Product and Services
7.11.4 Genmab Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Genmab Recent Developments/Updates
7.11.6 Genmab Competitive Strengths & Weaknesses
7.12 Alphamab Oncology
7.12.1 Alphamab Oncology Details
7.12.2 Alphamab Oncology Major Business
7.12.3 Alphamab Oncology Next-Generation Antibody Drug Product and Services
7.12.4 Alphamab Oncology Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Alphamab Oncology Recent Developments/Updates
7.12.6 Alphamab Oncology Competitive Strengths & Weaknesses
7.13 Akeso
7.13.1 Akeso Details
7.13.2 Akeso Major Business
7.13.3 Akeso Next-Generation Antibody Drug Product and Services
7.13.4 Akeso Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Akeso Recent Developments/Updates
7.13.6 Akeso Competitive Strengths & Weaknesses
7.14 Innovent Biologics
7.14.1 Innovent Biologics Details
7.14.2 Innovent Biologics Major Business
7.14.3 Innovent Biologics Next-Generation Antibody Drug Product and Services
7.14.4 Innovent Biologics Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Innovent Biologics Recent Developments/Updates
7.14.6 Innovent Biologics Competitive Strengths & Weaknesses
7.15 Yzy Medical Science & Technology
7.15.1 Yzy Medical Science & Technology Details
7.15.2 Yzy Medical Science & Technology Major Business
7.15.3 Yzy Medical Science & Technology Next-Generation Antibody Drug Product and Services
7.15.4 Yzy Medical Science & Technology Next-Generation Antibody Drug Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Yzy Medical Science & Technology Recent Developments/Updates
7.15.6 Yzy Medical Science & Technology Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Next-Generation Antibody Drug and Key Manufacturers
8.2 Next-Generation Antibody Drug Manufacturing Costs
8.3 Next-Generation Antibody Drug Production Process
8.4 Next-Generation Antibody Drug Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Next-Generation Antibody Drug Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Next-Generation Antibody Drug Typical Distributors
9.3 Next-Generation Antibody Drug Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Next-Generation Antibody Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Next-Generation Antibody Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Next-Generation Antibody Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Next-Generation Antibody Drug Production Value Market Share by Region (2017-2022)
Table 5. World Next-Generation Antibody Drug Production Value Market Share by Region (2023-2028)
Table 6. World Next-Generation Antibody Drug Production by Region (2017-2022) & (K Units)
Table 7. World Next-Generation Antibody Drug Production by Region (2023-2028) & (K Units)
Table 8. World Next-Generation Antibody Drug Production Market Share by Region (2017-2022)
Table 9. World Next-Generation Antibody Drug Production Market Share by Region (2023-2028)
Table 10. World Next-Generation Antibody Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Next-Generation Antibody Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Next-Generation Antibody Drug Major Market Trends
Table 13. World Next-Generation Antibody Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Next-Generation Antibody Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Next-Generation Antibody Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Next-Generation Antibody Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Next-Generation Antibody Drug Producers in 2021
Table 18. World Next-Generation Antibody Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Next-Generation Antibody Drug Producers in 2021
Table 20. World Next-Generation Antibody Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Next-Generation Antibody Drug Company Evaluation Quadrant
Table 22. World Next-Generation Antibody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Next-Generation Antibody Drug Production Site of Key Manufacturer
Table 24. Next-Generation Antibody Drug Market: Company Product Type Footprint
Table 25. Next-Generation Antibody Drug Market: Company Product Application Footprint
Table 26. Next-Generation Antibody Drug Competitive Factors
Table 27. Next-Generation Antibody Drug New Entrant and Capacity Expansion Plans
Table 28. Next-Generation Antibody Drug Mergers & Acquisitions Activity
Table 29. United States VS China Next-Generation Antibody Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Next-Generation Antibody Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Next-Generation Antibody Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Next-Generation Antibody Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Next-Generation Antibody Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Next-Generation Antibody Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Next-Generation Antibody Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Next-Generation Antibody Drug Production by Type (2017-2022) & (K Units)
Table 49. World Next-Generation Antibody Drug Production by Type (2023-2028) & (K Units)
Table 50. World Next-Generation Antibody Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Next-Generation Antibody Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Next-Generation Antibody Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Next-Generation Antibody Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Next-Generation Antibody Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Next-Generation Antibody Drug Production by Application (2017-2022) & (K Units)
Table 56. World Next-Generation Antibody Drug Production by Application (2023-2028) & (K Units)
Table 57. World Next-Generation Antibody Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Next-Generation Antibody Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Next-Generation Antibody Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Next-Generation Antibody Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Next-Generation Antibody Drug Product and Services
Table 64. Roche Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Next-Generation Antibody Drug Product and Services
Table 70. Amgen Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Janssen Basic Information, Manufacturing Base and Competitors
Table 74. Janssen Major Business
Table 75. Janssen Next-Generation Antibody Drug Product and Services
Table 76. Janssen Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Janssen Recent Developments/Updates
Table 78. Janssen Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Next-Generation Antibody Drug Product and Services
Table 82. Sanofi Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Next-Generation Antibody Drug Product and Services
Table 88. Pfizer Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Next-Generation Antibody Drug Product and Services
Table 94. Johnson & Johnson Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca Next-Generation Antibody Drug Product and Services
Table 100. AstraZeneca Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. AbbVie Basic Information, Manufacturing Base and Competitors
Table 104. AbbVie Major Business
Table 105. AbbVie Next-Generation Antibody Drug Product and Services
Table 106. AbbVie Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. AbbVie Recent Developments/Updates
Table 108. AbbVie Competitive Strengths & Weaknesses
Table 109. Lindis Biotech Basic Information, Manufacturing Base and Competitors
Table 110. Lindis Biotech Major Business
Table 111. Lindis Biotech Next-Generation Antibody Drug Product and Services
Table 112. Lindis Biotech Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lindis Biotech Recent Developments/Updates
Table 114. Lindis Biotech Competitive Strengths & Weaknesses
Table 115. MacroGenics, Inc Basic Information, Manufacturing Base and Competitors
Table 116. MacroGenics, Inc Major Business
Table 117. MacroGenics, Inc Next-Generation Antibody Drug Product and Services
Table 118. MacroGenics, Inc Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. MacroGenics, Inc Recent Developments/Updates
Table 120. MacroGenics, Inc Competitive Strengths & Weaknesses
Table 121. Genmab Basic Information, Manufacturing Base and Competitors
Table 122. Genmab Major Business
Table 123. Genmab Next-Generation Antibody Drug Product and Services
Table 124. Genmab Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Genmab Recent Developments/Updates
Table 126. Genmab Competitive Strengths & Weaknesses
Table 127. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 128. Alphamab Oncology Major Business
Table 129. Alphamab Oncology Next-Generation Antibody Drug Product and Services
Table 130. Alphamab Oncology Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Alphamab Oncology Recent Developments/Updates
Table 132. Alphamab Oncology Competitive Strengths & Weaknesses
Table 133. Akeso Basic Information, Manufacturing Base and Competitors
Table 134. Akeso Major Business
Table 135. Akeso Next-Generation Antibody Drug Product and Services
Table 136. Akeso Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Akeso Recent Developments/Updates
Table 138. Akeso Competitive Strengths & Weaknesses
Table 139. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 140. Innovent Biologics Major Business
Table 141. Innovent Biologics Next-Generation Antibody Drug Product and Services
Table 142. Innovent Biologics Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Innovent Biologics Recent Developments/Updates
Table 144. Yzy Medical Science & Technology Basic Information, Manufacturing Base and Competitors
Table 145. Yzy Medical Science & Technology Major Business
Table 146. Yzy Medical Science & Technology Next-Generation Antibody Drug Product and Services
Table 147. Yzy Medical Science & Technology Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Next-Generation Antibody Drug Raw Material
Table 149. Key Manufacturers of Next-Generation Antibody Drug Raw Materials
Table 150. Next-Generation Antibody Drug Typical Distributors
Table 151. Next-Generation Antibody Drug Typical Customers
Table 1. World Next-Generation Antibody Drug Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Next-Generation Antibody Drug Production Value by Region (2017-2022) & (USD Million)
Table 3. World Next-Generation Antibody Drug Production Value by Region (2023-2028) & (USD Million)
Table 4. World Next-Generation Antibody Drug Production Value Market Share by Region (2017-2022)
Table 5. World Next-Generation Antibody Drug Production Value Market Share by Region (2023-2028)
Table 6. World Next-Generation Antibody Drug Production by Region (2017-2022) & (K Units)
Table 7. World Next-Generation Antibody Drug Production by Region (2023-2028) & (K Units)
Table 8. World Next-Generation Antibody Drug Production Market Share by Region (2017-2022)
Table 9. World Next-Generation Antibody Drug Production Market Share by Region (2023-2028)
Table 10. World Next-Generation Antibody Drug Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Next-Generation Antibody Drug Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Next-Generation Antibody Drug Major Market Trends
Table 13. World Next-Generation Antibody Drug Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Next-Generation Antibody Drug Consumption by Region (2017-2022) & (K Units)
Table 15. World Next-Generation Antibody Drug Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Next-Generation Antibody Drug Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Next-Generation Antibody Drug Producers in 2021
Table 18. World Next-Generation Antibody Drug Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Next-Generation Antibody Drug Producers in 2021
Table 20. World Next-Generation Antibody Drug Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Next-Generation Antibody Drug Company Evaluation Quadrant
Table 22. World Next-Generation Antibody Drug Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Next-Generation Antibody Drug Production Site of Key Manufacturer
Table 24. Next-Generation Antibody Drug Market: Company Product Type Footprint
Table 25. Next-Generation Antibody Drug Market: Company Product Application Footprint
Table 26. Next-Generation Antibody Drug Competitive Factors
Table 27. Next-Generation Antibody Drug New Entrant and Capacity Expansion Plans
Table 28. Next-Generation Antibody Drug Mergers & Acquisitions Activity
Table 29. United States VS China Next-Generation Antibody Drug Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Next-Generation Antibody Drug Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Next-Generation Antibody Drug Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Next-Generation Antibody Drug in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Next-Generation Antibody Drug in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Next-Generation Antibody Drug in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Next-Generation Antibody Drug Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Next-Generation Antibody Drug Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Next-Generation Antibody Drug Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Next-Generation Antibody Drug Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Next-Generation Antibody Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Next-Generation Antibody Drug Production by Type (2017-2022) & (K Units)
Table 49. World Next-Generation Antibody Drug Production by Type (2023-2028) & (K Units)
Table 50. World Next-Generation Antibody Drug Production Value by Type (2017-2022) & (USD Million)
Table 51. World Next-Generation Antibody Drug Production Value by Type (2023-2028) & (USD Million)
Table 52. World Next-Generation Antibody Drug Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Next-Generation Antibody Drug Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Next-Generation Antibody Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Next-Generation Antibody Drug Production by Application (2017-2022) & (K Units)
Table 56. World Next-Generation Antibody Drug Production by Application (2023-2028) & (K Units)
Table 57. World Next-Generation Antibody Drug Production Value by Application (2017-2022) & (USD Million)
Table 58. World Next-Generation Antibody Drug Production Value by Application (2023-2028) & (USD Million)
Table 59. World Next-Generation Antibody Drug Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Next-Generation Antibody Drug Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Next-Generation Antibody Drug Product and Services
Table 64. Roche Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Next-Generation Antibody Drug Product and Services
Table 70. Amgen Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Janssen Basic Information, Manufacturing Base and Competitors
Table 74. Janssen Major Business
Table 75. Janssen Next-Generation Antibody Drug Product and Services
Table 76. Janssen Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Janssen Recent Developments/Updates
Table 78. Janssen Competitive Strengths & Weaknesses
Table 79. Sanofi Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi Major Business
Table 81. Sanofi Next-Generation Antibody Drug Product and Services
Table 82. Sanofi Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sanofi Recent Developments/Updates
Table 84. Sanofi Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Next-Generation Antibody Drug Product and Services
Table 88. Pfizer Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Next-Generation Antibody Drug Product and Services
Table 94. Johnson & Johnson Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 98. AstraZeneca Major Business
Table 99. AstraZeneca Next-Generation Antibody Drug Product and Services
Table 100. AstraZeneca Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. AstraZeneca Recent Developments/Updates
Table 102. AstraZeneca Competitive Strengths & Weaknesses
Table 103. AbbVie Basic Information, Manufacturing Base and Competitors
Table 104. AbbVie Major Business
Table 105. AbbVie Next-Generation Antibody Drug Product and Services
Table 106. AbbVie Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. AbbVie Recent Developments/Updates
Table 108. AbbVie Competitive Strengths & Weaknesses
Table 109. Lindis Biotech Basic Information, Manufacturing Base and Competitors
Table 110. Lindis Biotech Major Business
Table 111. Lindis Biotech Next-Generation Antibody Drug Product and Services
Table 112. Lindis Biotech Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lindis Biotech Recent Developments/Updates
Table 114. Lindis Biotech Competitive Strengths & Weaknesses
Table 115. MacroGenics, Inc Basic Information, Manufacturing Base and Competitors
Table 116. MacroGenics, Inc Major Business
Table 117. MacroGenics, Inc Next-Generation Antibody Drug Product and Services
Table 118. MacroGenics, Inc Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. MacroGenics, Inc Recent Developments/Updates
Table 120. MacroGenics, Inc Competitive Strengths & Weaknesses
Table 121. Genmab Basic Information, Manufacturing Base and Competitors
Table 122. Genmab Major Business
Table 123. Genmab Next-Generation Antibody Drug Product and Services
Table 124. Genmab Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Genmab Recent Developments/Updates
Table 126. Genmab Competitive Strengths & Weaknesses
Table 127. Alphamab Oncology Basic Information, Manufacturing Base and Competitors
Table 128. Alphamab Oncology Major Business
Table 129. Alphamab Oncology Next-Generation Antibody Drug Product and Services
Table 130. Alphamab Oncology Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Alphamab Oncology Recent Developments/Updates
Table 132. Alphamab Oncology Competitive Strengths & Weaknesses
Table 133. Akeso Basic Information, Manufacturing Base and Competitors
Table 134. Akeso Major Business
Table 135. Akeso Next-Generation Antibody Drug Product and Services
Table 136. Akeso Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Akeso Recent Developments/Updates
Table 138. Akeso Competitive Strengths & Weaknesses
Table 139. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 140. Innovent Biologics Major Business
Table 141. Innovent Biologics Next-Generation Antibody Drug Product and Services
Table 142. Innovent Biologics Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Innovent Biologics Recent Developments/Updates
Table 144. Yzy Medical Science & Technology Basic Information, Manufacturing Base and Competitors
Table 145. Yzy Medical Science & Technology Major Business
Table 146. Yzy Medical Science & Technology Next-Generation Antibody Drug Product and Services
Table 147. Yzy Medical Science & Technology Next-Generation Antibody Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Next-Generation Antibody Drug Raw Material
Table 149. Key Manufacturers of Next-Generation Antibody Drug Raw Materials
Table 150. Next-Generation Antibody Drug Typical Distributors
Table 151. Next-Generation Antibody Drug Typical Customers
LIST OF FIGURES
Figure 1. Next-Generation Antibody Drug Picture
Figure 2. World Next-Generation Antibody Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Next-Generation Antibody Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 5. World Next-Generation Antibody Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Next-Generation Antibody Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Next-Generation Antibody Drug Production Market Share by Region (2017-2028)
Figure 8. North America Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 9. Europe Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 10. China Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 11. Japan Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 12. Next-Generation Antibody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Next-Generation Antibody Drug Demand (2017-2028) & (K Units)
Figure 15. World Next-Generation Antibody Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 17. China Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 22. India Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Next-Generation Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Next-Generation Antibody Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Next-Generation Antibody Drug Markets in 2021
Figure 26. United States VS China: Next-Generation Antibody Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Next-Generation Antibody Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Next-Generation Antibody Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Next-Generation Antibody Drug in United States
Figure 30. Key Producers and Market Share of Next-Generation Antibody Drug in China
Figure 31. Key Producers and Market Share of Next-Generation Antibody Drug in Rest of World
Figure 32. World Next-Generation Antibody Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Next-Generation Antibody Drug Production Value Market Share by Type in 2021
Figure 34. Fragment-Based
Figure 35. IgG-Based
Figure 36. World Next-Generation Antibody Drug Production Market Share by Type (2017-2028)
Figure 37. World Next-Generation Antibody Drug Production Value Market Share by Type (2017-2028)
Figure 38. World Next-Generation Antibody Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Next-Generation Antibody Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Next-Generation Antibody Drug Production Value Market Share by Application in 2021
Figure 41. Cancer
Figure 42. Hemophilia
Figure 43. Other Diseases
Figure 44. World Next-Generation Antibody Drug Production Market Share by Application (2017-2028)
Figure 45. World Next-Generation Antibody Drug Production Value Market Share by Application (2017-2028)
Figure 46. World Next-Generation Antibody Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Next-Generation Antibody Drug in 2021
Figure 48. Manufacturing Process Analysis of Next-Generation Antibody Drug
Figure 49. Next-Generation Antibody Drug Industrial Chain
Figure 50. Distribution Channel Breakdown for Next-Generation Antibody Drug Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Next-Generation Antibody Drug Picture
Figure 2. World Next-Generation Antibody Drug Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Next-Generation Antibody Drug Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 5. World Next-Generation Antibody Drug Average Price (2017-2028) & (US$/Unit)
Figure 6. World Next-Generation Antibody Drug Production Value Market Share by Region (2017-2028)
Figure 7. World Next-Generation Antibody Drug Production Market Share by Region (2017-2028)
Figure 8. North America Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 9. Europe Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 10. China Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 11. Japan Next-Generation Antibody Drug Production (2017-2028) & (K Units)
Figure 12. Next-Generation Antibody Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Next-Generation Antibody Drug Demand (2017-2028) & (K Units)
Figure 15. World Next-Generation Antibody Drug Consumption Market Share by Region (2017-2028)
Figure 16. United States Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 17. China Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 18. Europe Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 19. Japan Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 20. South Korea Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 22. India Next-Generation Antibody Drug Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Next-Generation Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Next-Generation Antibody Drug Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Next-Generation Antibody Drug Markets in 2021
Figure 26. United States VS China: Next-Generation Antibody Drug Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Next-Generation Antibody Drug Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Next-Generation Antibody Drug Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Next-Generation Antibody Drug in United States
Figure 30. Key Producers and Market Share of Next-Generation Antibody Drug in China
Figure 31. Key Producers and Market Share of Next-Generation Antibody Drug in Rest of World
Figure 32. World Next-Generation Antibody Drug Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Next-Generation Antibody Drug Production Value Market Share by Type in 2021
Figure 34. Fragment-Based
Figure 35. IgG-Based
Figure 36. World Next-Generation Antibody Drug Production Market Share by Type (2017-2028)
Figure 37. World Next-Generation Antibody Drug Production Value Market Share by Type (2017-2028)
Figure 38. World Next-Generation Antibody Drug Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Next-Generation Antibody Drug Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Next-Generation Antibody Drug Production Value Market Share by Application in 2021
Figure 41. Cancer
Figure 42. Hemophilia
Figure 43. Other Diseases
Figure 44. World Next-Generation Antibody Drug Production Market Share by Application (2017-2028)
Figure 45. World Next-Generation Antibody Drug Production Value Market Share by Application (2017-2028)
Figure 46. World Next-Generation Antibody Drug Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Next-Generation Antibody Drug in 2021
Figure 48. Manufacturing Process Analysis of Next-Generation Antibody Drug
Figure 49. Next-Generation Antibody Drug Industrial Chain
Figure 50. Distribution Channel Breakdown for Next-Generation Antibody Drug Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
